LiPO Teen (the Lifestyle in Pregnancy and Offspring Teenagers): Identification of Modifiable Risk Factors for Childhood Obesity - a Follow-up of a Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The study is a follow-up of a Randomized Controlled Trial (RCT) performed in 2007-10 - the Lifestyle in Pregnancy LiP study. The LiP study included 360 pregnant women with BMI ≥30 kg/m2 from Odense University Hospital and Aarhus University Hospital. The women were randomized to intervention with low-calorie diet and physical activity from gestational age 10-14 in pregnancy and until delivery - or to a standard care control group. The objective of the LiPO-Teen project is to perform a clinical follow-up study of the eligible 301 mothers who completed the trial until delivery with a liveborn child, and their 14 year-old offspring. The overall ambition is to understand whether lifestyle intervention in pregnancy prevents obesity and its complications across generations, with a specific focus on modifiable factors.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 13
Maximum Age: 65
Healthy Volunteers: t
View:

• Mothers in the initial LiP study selected at the baseline study in 2007-2010

• Teenagers of mothers in the initial LiP study

Locations
Other Locations
Denmark
Steno Diabetes Center Odense
RECRUITING
Odense
Contact Information
Primary
Christina A. Vinter, M.D. Ph.D.
Christina.vinter@rsyd.dk
+45 21782118
Backup
Birgitte M. Luef, M.D
Birgitte.moller.luef@rsyd.dk
Time Frame
Start Date: 2023-10-26
Estimated Completion Date: 2026-04-01
Participants
Target number of participants: 301
Treatments
Experimental: Diet + physical activity
Diet + physical activity Dietary advise and advise on physical activity
No_intervention: Control group
No intervention
Related Therapeutic Areas
Sponsors
Leads: Odense University Hospital
Collaborators: University of Southern Denmark, Steno Diabetes Center Odense, University of Aarhus, Statens Serum Institut, Aarhus University Hospital

This content was sourced from clinicaltrials.gov